(-)-Epicatechin
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
(-)-Epicatechin. Cocoa flavanol that suppresses myostatin and improves NO.
How it works. Inhibits myostatin/SMAD signaling; activates eNOS.
What the research supports. 1 graded claims. Strongest: Increases follistatin:myostatin ratio in humans (limited).
How much to take. Typical dose: 100–200 mg.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Creatine monohydrate, Whey or EAAs.
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried (-)-Epicatechin. Anecdotes are not medical advice.
(-)-Epicatechin. Cocoa flavanol that suppresses myostatin and improves NO.
What it is
Cocoa flavanol that suppresses myostatin and improves NO.
Also called
Food sources
Goals
How it works
Inhibits myostatin/SMAD signaling; activates eNOS.
Pathways
- Inhibits myostatin/SMAD signaling
- activates eNOS
Effects
- ↑follistatin:myostatin ratio in humans increases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Headache
Medication interactions
Always disclose (-)-Epicatechin use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Creatine monohydrateFoundational support for strength, power, and lean mass.
- Whey or EAAsProvides amino acid substrate for muscle protein synthesis.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching (-)-Epicatechin and "Increases follistatin:myostatin ratio in humans". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching (-)-Epicatechin and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching (-)-Epicatechin and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…